Absci to Participate in the TD Cowen 45th Annual Health Care Conference

Core Insights - Absci Corporation, a data-first generative AI drug creation company, will participate in the TD Cowen 45th Annual Health Care Conference in Boston, MA [1] - The management of Absci is scheduled for a fireside chat on March 3 at 3:10 p.m. Eastern Time, with a live and archived webcast available [2] - Absci's Integrated Drug Creation™ platform combines AI with scalable wet lab technologies to accelerate drug development and increase success rates [3] Company Overview - Absci specializes in generative AI for drug creation, aiming to produce better biologics more quickly for patients [3] - The company can screen billions of cells weekly, transitioning from AI-designed candidates to wet lab-validated candidates in as little as six weeks [3] - Absci operates from Vancouver, WA, with an AI Research Lab in New York City and an Innovation Center in Zug, Switzerland [3]